These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 22728642

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
    Cabral H, Nishiyama N, Kataoka K.
    Acc Chem Res; 2011 Oct 18; 44(10):999-1008. PubMed ID: 21755933
    [Abstract] [Full Text] [Related]

  • 6. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y, Fuchigami T, Tada N, Kawamura R, Matsunuma S, Kitamoto Y, Nakagawa M.
    Acc Chem Res; 2011 Oct 18; 44(10):1080-93. PubMed ID: 21786832
    [Abstract] [Full Text] [Related]

  • 7. Biomedical nanotechnology for cancer.
    Pope-Harman A, Cheng MM, Robertson F, Sakamoto J, Ferrari M.
    Med Clin North Am; 2007 Sep 18; 91(5):899-927. PubMed ID: 17826110
    [Abstract] [Full Text] [Related]

  • 8. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
    Wong XY, Sena-Torralba A, Álvarez-Diduk R, Muthoosamy K, Merkoçi A.
    ACS Nano; 2020 Mar 24; 14(3):2585-2627. PubMed ID: 32031781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Personalized nanomedicine.
    Lammers T, Rizzo LY, Storm G, Kiessling F.
    Clin Cancer Res; 2012 Sep 15; 18(18):4889-94. PubMed ID: 22829203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F, Jin C, Subedi S, Lee CL, Wang Q, Jiang Y, Li J, Di Y, Fu D.
    Cancer Treat Rev; 2012 Oct 15; 38(6):566-79. PubMed ID: 22655679
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Towards tailored management of malignant brain tumors with nanotheranostics.
    Aparicio-Blanco J, Torres-Suárez AI.
    Acta Biomater; 2018 Jun 15; 73():52-63. PubMed ID: 29678675
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Omics-based nanomedicine: the future of personalized oncology.
    Rosenblum D, Peer D.
    Cancer Lett; 2014 Sep 28; 352(1):126-36. PubMed ID: 23941830
    [Abstract] [Full Text] [Related]

  • 17. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.
    Muthu MS, Mei L, Feng SS.
    Nanomedicine (Lond); 2014 Jul 28; 9(9):1277-80. PubMed ID: 25204816
    [No Abstract] [Full Text] [Related]

  • 18. Immunomicelles for advancing personalized therapy.
    Sawant RR, Jhaveri AM, Torchilin VP.
    Adv Drug Deliv Rev; 2012 Oct 28; 64(13):1436-46. PubMed ID: 22917778
    [Abstract] [Full Text] [Related]

  • 19. Lipid- and polymer-based nanostructures for cancer theranostics.
    Luk BT, Fang RH, Zhang L.
    Theranostics; 2012 Oct 28; 2(12):1117-26. PubMed ID: 23382770
    [Abstract] [Full Text] [Related]

  • 20. Nanomedicine and drug delivery.
    Wei C, Wei W, Morris M, Kondo E, Gorbounov M, Tomalia DA.
    Med Clin North Am; 2007 Sep 28; 91(5):863-70. PubMed ID: 17826106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.